July 7th 2025, 1:00pm
Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment.
July 6th 2025, 6:00pm
TIL therapy is on the rise in melanoma, with potential for other tumor types.
July 6th 2025, 2:00pm
At 12 years of age, I felt embarrassed by my mother’s cancer, but at 47, I see her as the strongest, most beautiful warrior I’ve ever known.
July 5th 2025, 6:00pm
Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic status.
July 5th 2025, 2:00pm
Zac Mirecki reflects on six years of survivorship, sharing how his AML journey taught him to priori-tize self-care, seek connection, and support others through advocacy.
July 4th 2025, 7:00pm
Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, and honor my journey with purpose.
July 4th 2025, 1:00pm
Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.
July 3rd 2025, 7:00pm
Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.
July 3rd 2025, 5:00pm
A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) therapy.
July 3rd 2025, 1:00pm
Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia and renewed gratitude.
Understanding Your Diagnosis: Stage 2 Oral Cavity Cancer
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients